223 related articles for article (PubMed ID: 29808267)
1. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
Fond G; Godin O; Boyer L; Berna F; Andrianarisoa M; Coulon N; Brunel L; Bulzacka E; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Schürhoff F; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):985-992. PubMed ID: 29808267
[TBL] [Abstract][Full Text] [Related]
2. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
[TBL] [Abstract][Full Text] [Related]
3. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
[TBL] [Abstract][Full Text] [Related]
4. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
Fond G; Berna F; Andrianarisoa M; Godin O; Leboyer M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Richieri R; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Schürhoff F;
Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):465-472. PubMed ID: 28238173
[TBL] [Abstract][Full Text] [Related]
5. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
[TBL] [Abstract][Full Text] [Related]
6. Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study.
Leboyer M; Godin O; Terro E; Boukouaci W; Lu CL; Andre M; Aouizerate B; Berna F; Barau C; Capdevielle D; Clauss-Kobayashi J; Chereau I; D Amato T; Dubertret C; Dubreucq J; Fond G; Laouamri H; Leignier S; Lancon C; Llorca PM; Mallet J; Le Corvoisier P; Misdrahi D; Passerieux C; Rey R; Pignon B; Urbach M; Szoke A; Schürhoff F; Tamouza R;
Schizophr Bull Open; 2021 Jan; 2(1):sgab012. PubMed ID: 34901861
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
Fond G; Faugere M; Richieri R; Cermolacce M; Korchia T; Micoulaud-Franchi JA; Sunhary de Verville PL; Boyer L; Lançon C
J Affect Disord; 2021 Feb; 280(Pt A):267-271. PubMed ID: 33220563
[TBL] [Abstract][Full Text] [Related]
8. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
Fond G; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D' Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109927. PubMed ID: 32173456
[TBL] [Abstract][Full Text] [Related]
9. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.
Fond G; Boyer L; Schürhoff F; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Leboyer M;
Schizophr Res; 2018 Nov; 201():373-380. PubMed ID: 29843964
[TBL] [Abstract][Full Text] [Related]
10. Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort.
Fond G; Bulzacka E; Boucekine M; Schürhoff F; Berna F; Godin O; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():8-18. PubMed ID: 30552914
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
Fond G; Berna F; Boyer L; Godin O; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chereau I; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Portalier C; Roux P; Vehier A; Yazbek H; Schürhoff F; Bulzacka E;
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):17-26. PubMed ID: 28349247
[TBL] [Abstract][Full Text] [Related]
12. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M;
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539
[TBL] [Abstract][Full Text] [Related]
13. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G;
Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795
[TBL] [Abstract][Full Text] [Related]
14. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.
Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):332-339. PubMed ID: 28663115
[TBL] [Abstract][Full Text] [Related]
15. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
[TBL] [Abstract][Full Text] [Related]
18. Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
Andrianarisoa M; Boyer L; Godin O; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Tronche AM; Urbach M; Vidailhet P; Schürhoff F; Fond G;
Schizophr Res; 2017 Jul; 185():173-181. PubMed ID: 28109668
[TBL] [Abstract][Full Text] [Related]
19. Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort.
Fond G; Godin O; Dumontaud M; Faget C; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Szoke A; Urbach M; Vidailhet P; Leboyer M; Lançon C; Boyer L; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109654. PubMed ID: 31125587
[TBL] [Abstract][Full Text] [Related]
20. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]